TRIOLAB AS

Org. no. 963538952 · LILLESTRØM · Founded 1992 · 47 employees

Score · fiscal year 2025

60of 100

How to read this: the company is ahead of 71 % of medium-sized companies in the same sector in 2025. What does this mean?

Rank: 11,644 of 38,670 · Handel

Profile

Cheetah · Sprinter

High profitability, lower solidity

Position against comparable companies in 2025, not a verdict on the company. Based on profitability 93 and solidity 32 out of 100 among medium-sized companies in the same sector in 2025. Methodology

Against the sector

TRIOLAB AS is 11 points above the median for medium-sized companies in the same sector in 2025.

Median score 49 among 2,198 companies.

Against medium-sized companies in the same sector in 2025: operating margin 13.3% (median 3.2%) and equity ratio 23.4% (median 32.6%).

Source: Register of Company Accounts and Central Coordinating RegisterFetched 28 October 2026Report an issue
Key figures · 2025

The numbers behind the score

The numbers behind the score · 2025
MeasureCompanyMedianAhead of
Operating revenue337 MNOK173 MNOK
Operating margin 13.3% 3.2% 93 %
Profit margin 13.5% 3.2% shown, not part of the index
Return on assets 38.7% 11.6% 94 %
Equity ratio 23.4% 32.6% 33 %
Debt-to-equity 3.28 2.03 32 %
Current ratio 1.24 1.38 38 %
Revenue growth 13.1% 6.8% 67 %
Revenue per employee7.17 MNOK6.45 MNOK

The median and “ahead of” refer to medium-sized companies in the same sector in 2025. The bar shows the share of companies the figure is ahead of.

With an index of 60, TRIOLAB AS does better than 71% of medium-sized companies in the same sector (2,203 companies) in 2025.

Over time

Score 2023–2025

CompanyMedian0255075100202320242025
  • TRIOLAB AS
  • Median: medium-sized companies in the same sector
Summary analysis

TRIOLAB AS has a score of 60 for 2025, rank 11,644 of 38,670 in the sector.

Strongest: Profitability: percentile 93 against peers, operating margin 13.3% against a median of 3.2%. Growth: percentile 67 against peers, revenue growth 13.1% against a median of 6.8%.

Weakest: Solidity: percentile 32 against peers, equity ratio 23.4% against a median of 32.6%. Liquidity: percentile 38 against peers, current ratio 1.24 against a median of 1.38.

Worth a closer look

Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made

Analysis · 2025

What the numbers say

TRIOLAB AS had an operating margin of 13.3% and an equity ratio of 23.4% in 2025, and ranks 11,644 of 38,670 in Handel.

From 2024 to 2025: revenue grew by 13%.

This text is generated automatically from the 2025 accounts.

Estimated value · 2025

Three simple methods

The methods give between 29 MNOK and 424 MNOK.

MethodInputMultipleEstimate
P/E Net profit: 35.4 MNOK 10.0 354 MNOK
EV/EBIT Operating profit: 44.9 MNOK
minus net debt −64.1 MNOK
8.0 424 MNOK
P/B Equity: 29.0 MNOK 1.0 29 MNOK

A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation

Indications · 2025

Worth a closer look

No rules were triggered for this year.

Indications based on the latest annual accounts from open data. Not investment or financial advice.

Financial costs were 2.7% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.

Data quality

No anomalies found in the figures.

Stress test · 2017

Scenario analysis: the sector's weakest year

We have no accounts for 2017, the sector's weakest year, for this company.

The sector's weakest year was 2017, with a median operating margin of −65.6%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology

Components · 2025

What the score is made of

Profitability93 weight 30%
Solidity32 weight 25%
Liquidity38 weight 15%
Growth67 weight 15%
Consistency52 weight 15%

Durability: 61 (average over 3 years)

Index version 2. Data completeness 100%: the share of the weights that had data.

2025

Questions and answers

How profitable is TRIOLAB AS?

The operating margin was 13.3% in 2025, against a median of 3.2% among medium-sized companies in the same sector. Return on assets was 38.7%.

How solid is TRIOLAB AS?

The equity ratio was 23.4% in 2025 (median 32.6%). Debt-to-equity was 3.28 (median 2.03).

What is the liquidity of TRIOLAB AS like?

The current ratio was 1.24 in 2025 (median 1.38).

How does TRIOLAB AS compare in Handel?

TRIOLAB AS ranks 11,644 of 38,670 in Handel for 2025. Among companies of the same size (medium-sized companies) it ranks 638 of 2,203. Revenue changed by 13.1% from the year before.

Public contracts

Contracts awarded since 2024
16
in 15 notices (lots counted separately)
Total awarded value since 2024
24.8 MNOK
5 contracts without a stated value are not in the total.
Framework agreements
7
Left out of the total: the value is a ceiling, not actual spend.
DateBuyerNotice ValueCPV
16 October 2026 SYKEHUSINNKJØP HF Osmometer til Sørlandet Sykehus HF 4.4 MNOK 38000000
3 July 2026 SYKEHUSINNKJØP HF Kontraktstildeling: Generelle forbruksvarer til patologi ved helseforetakene i Helse Vest RHF 34.2 MNOK (framework) 38000000
16 June 2026 Oslo Universitetssykehus HF (hovedenhet) 78015_78031 RH KLM PAT Fremføringsmaskin - Ny utlysning 12.0 MNOK 38000000
30 March 2026 STATSBYGG 1105601 UiO Livsvitenskap brukerutstyr. K930.15 Platelesere og platevasker 0.4 MNOK 38000000
17 March 2026 UNIVERSITETET I INNLANDET Rammeavtale på forbruksmateriell til blodgassapparater 1.2 MNOK (framework) 33140000
29 January 2026 Oslo Universitetssykehus HF (hovedenhet) 77330 RH KLM Avdeling for patologi Oppleggsmaskin 2. utlysning 8.0 MNOK 33919000
28 January 2026 SYKEHUSINNKJØP HF Kontraktstildeling: Avlesere og forbruksvarer til analysering av hemoglobin for levering til helseforetakene i Helse Vest 9.4 MNOK (framework) 38000000
24 April 2025 Sykehusbygg HF K9270 Spesialutstyr mikrobiologi *KUNNGJØRING KONTRAKTSTILDELING* value not stated (2 lots) 33698100
27 January 2025 Helse Bergen HF Vevstyping (HLA-B27 og Cøliaki) til AIT for levering til Helse Bergen HF value not stated 38000000
13 December 2024 SYKEHUSINNKJØP HF HPV-test og analyseplattform til helseforetak i Norge value not stated 38500000

Based on notices in Doffin. Does not show call-offs under framework agreements or purchases below the publication threshold. Values are as stated by the buyer.

Source: Doffin (DFØ), fetched 28 October 2026. Winners are matched on organisation number.

Contains data under the Norwegian licence for public data (NLOD 2.0) made available by Doffin/the Norwegian Agency for Public and Financial Management (DFØ). NLOD 2.0

From the Central Coordinating Register

Org. no.
963538952
Legal form
AS
Sector
Handel (46.460)
Size tier
medium
Employees
47 registered 10 October 2026
Founded
2 January 1992 34 years in operation
Share capital
0.55 MNOK
Business address
Jogstadveien 21, 2007 KJELLER (LILLESTRØM)
Municipality
Lillestrøm rank 7 of 11 in KOSTRA group 12
Latest accounts filed
2025
Website
www.triolab.no
LEI
5493003RCL64L7KWWD58 not renewed (lapsed)

Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre

Ownership and roles

Chief executive
Gøran Lysø-Jakobsen
Chair of the board
Kai Tapani Rantanen
Board member
Göran Fredrik Brandt
Auditor
TELL NORGE AS

Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.

Parent company
AddLife Development AB (Sweden)
Ultimate parent
AddLife AB (Sweden)

Foreign-owned according to GLEIF.

Source: GLEIF (Global Legal Entity Identifier Foundation), fetched 29 October 2026. The parent is the one the company itself reported to GLEIF.

Owners and shareholdings will appear here once the shareholder data extract is in place.

Coming · not built yet

Error in the data?

Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.

Report an issue

Figures last fetched 28 October 2026.

Details

Year by year · 2023–2025

Key figure202320242025Trend
Index626160
Rank10,24910,47411,644
Operating margin14.8%12.9%13.3%
Return on assets39.1%36.4%38.7%
Equity ratio25.8%25.7%23.4%
Current ratio1.291.291.24
Revenue growth–9.0%13.1%

Accounts

From the Brønnøysund Register Centre, in the company's reporting currency (NOK).

Key figure202320242025
Operating revenue273.3 MNOK297.9 MNOK337.0 MNOK
Operating profit40.5 MNOK38.6 MNOK44.9 MNOK
Profit before tax40.6 MNOK38.5 MNOK45.4 MNOK
Net profit31.6 MNOK30.0 MNOK35.4 MNOK
Financial expenses3.4 MNOK2.7 MNOK2.5 MNOK
Total assets112.4 MNOK113.2 MNOK124.0 MNOK
Current assets108.0 MNOK108.2 MNOK117.7 MNOK
Equity29.0 MNOK29.0 MNOK29.0 MNOK
Retained earnings28.5 MNOK28.5 MNOK28.4 MNOK
Total liabilities83.4 MNOK84.1 MNOK95.1 MNOK
Current liabilities83.4 MNOK84.1 MNOK95.1 MNOK

Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 28 October 2026, accounts id 6546217.

Similar companies